AMH Explained — What Your Result Means, and What It Does Not (2026)

AMH is produced by the small, early-stage follicles in your ovaries, so the level in your blood tracks roughly how many of those follicles you have. It is a measure of quantity — how many eggs remain — and nothing else.

That single sentence resolves most of the confusion around AMH. It is a headcount. It does not describe the eggs, only how many there are, and the distinction turns out to matter more than almost anything else on your report.

• AMH reflects egg quantity, not egg quality; quality tracks with age.
• In a study of 981 women aged 30-44, low AMH did not reduce the probability of conceiving by cycle 6 or 12.
• The authors concluded AMH should not be used to predict natural fertility, exclude patients from treatment, or predict menopause age.
• AMH does usefully predict ovarian response to stimulation, which is why it guides IVF drug dosing.

Because it reflects a standing pool rather than a monthly event, AMH can be measured at any point in the cycle, which is part of why it became popular. Convenience is a poor reason to over-read a result, and over-reading is exactly what tends to happen.

It is reported in either ng/mL or pmol/L, and laboratories in India use both. To convert between them, multiply ng/mL by roughly 7.14. A result of "2" means something entirely different depending on which unit is on the report, and comparing your figure against a range quoted in the other unit is one of the most common ways people frighten themselves unnecessarily.

Assay platforms also differ between laboratories. If you are tracking AMH over time, use the same laboratory each time, or the trend is not measuring what you think it is.

AMH is usually read alongside two other things: your antral follicle count, which counts the same follicles directly on ultrasound, and your age. Those three together support a reasonable estimate of how you will respond to stimulation. Any one of them alone supports considerably less.

On the best available evidence, no. A prospective study of 981 women aged 30 to 44 with no history of infertility found that those with low AMH did not have a lower probability of conceiving by cycle six or cycle twelve than women with normal levels.

This is not a small or preliminary finding. The women were recruited from the community rather than from a fertility clinic, and were followed from the start of trying, which is precisely the group most likely to be handed an AMH result and a grim interpretation.

The study went further than showing no harm. In every age group, low AMH was not associated with reduced fecundability, and the point estimates actually suggested slightly higher fecundability among women with low AMH — which is best read as evidence of no relationship rather than as a benefit.

The authors' conclusion was direct: AMH should not be used to predict natural fertility, to exclude patients from assisted reproduction, or to predict the age of menopause.

• GnRH Antagonist vs Agonist Protocol — Which IVF Protocol, and Why (2026)
• Best Age to Conceive: What the Data Says About Planning
• IVF Side Effects: What OHSS Is and How It Is Prevented
• Semen Analysis Report — How to Read Yours, Line by Line (India 2026)
• Fertility Myths vs Facts: Ten Claims Checked Against the Evidence
• Can Stress Cause Infertility? What the Evidence Actually Shows
• IVF Success Rates: How to Read the Numbers You Are Quoted

Because it does one job well: predicting how your ovaries will respond to stimulation drugs. That is a question about how many follicles can be recruited in a cycle, which is exactly what a follicle count is good for.

This is why AMH belongs in IVF planning and why it is used to choose a starting dose of gonadotropin. A woman with a very low AMH is likely to yield fewer eggs from a given dose, and knowing that in advance genuinely changes the protocol.

The error is in carrying that predictive power across to a different question. Being able to forecast the response to a drug does not confer the ability to forecast a natural pregnancy, and the evidence above shows it does not.

The distinction is easier to hold with an analogy. Knowing how many people are in a building tells you a great deal about how many will come out if you open all the doors at once.

It tells you much less about whether any particular person will walk out on their own this afternoon. Stimulation opens all the doors; natural conception does not.

There is a second legitimate use. A very high AMH flags a risk of over-response and ovarian hyperstimulation syndrome, which changes protocol and trigger choices. That is again a prediction about how the ovaries behave under drugs, which is the thing AMH is genuinely good at.

No. AMH counts follicles; it says nothing about whether the eggs inside them are chromosomally normal. One study in women of advanced age undergoing IVF or ICSI concluded AMH has no role in predicting oocyte quality.

Quality tracks with age, not with AMH, and the two can point in opposite directions. A woman of 31 with a low AMH generally has better egg quality than a woman of 42 with a high one, because the variable driving quality is not the one being measured.

This is the practical reason a low AMH at a young age is a different situation from a low AMH at 40. The number may be identical; what it implies is not. Our explanation of what diminished ovarian reserve means covers the distinction in more depth, and how age impacts female fertility covers the variable that is actually doing the work.

Read it as information about likely response to treatment, not as a verdict on whether you can conceive. It should be interpreted alongside your age, your antral follicle count and your history — never on its own.

• AMH estimates quantity. It does not measure egg quality.
• It does not predict natural conception, on the best available cohort evidence.
• It should not be used to exclude anyone from treatment.
• It does usefully predict ovarian response, which is why it guides IVF dosing.
• It does not reliably predict the age of menopause.

If a low AMH is being used to push you toward treatment faster than you are ready for, that is worth questioning. Urgency based on an AMH figure alone is not supported by the evidence, and age remains the variable that genuinely rewards acting sooner.

It cannot tell you when you will run out of eggs, whether this cycle will work, or whether your eggs are chromosomally normal. It also varies between laboratory assays, so tracking a trend across different labs is not meaningful.

A single AMH figure has become one of the most emotionally loaded numbers in fertility care, and the weight it carries is out of proportion to what it measures. It is one input among several, and on the question most people are actually asking — can I get pregnant — it is close to silent.

None of that makes it a bad test. It makes it a specific test, useful for a specific purpose, routinely asked to answer questions it was never able to answer.

It is worth saying what a low AMH does legitimately change, because the answer is not nothing. It affects the expected number of eggs from a cycle, which affects how many embryos you might reach, which affects whether one retrieval is likely to be enough. Those are real planning consequences and they belong in the conversation.

What they are not is a statement about whether you can conceive. A woman told she has a low AMH is usually hearing something about her likely IVF yield being presented as something about her fertility, and those are different claims with different evidence behind them.

There is little to gain from it. AMH does not predict natural conception and does not reliably predict the age of menopause, so for a woman not undergoing fertility treatment it answers no question she is likely to be asking.

Direct-to-consumer AMH testing has grown quickly on the promise of an "ovarian reserve check", and the promise outruns what the test does. A result arriving without clinical context, without an antral follicle count beside it and without anyone to interpret it tends to produce anxiety rather than information.

If you are considering egg freezing, the case is different — there the question genuinely is how many eggs a stimulation cycle might yield, which is what AMH predicts. Testing when the decision in front of you depends on ovarian response is reasonable. Testing to find out whether you are fertile is not, because the test does not report that.